Biomerica (BMRA) Change in Inventory (2010 - 2026)
Biomerica (BMRA) reported Change in Inventory of $84000.0 for Q1 2026, up 146.41% on a YoY basis from $34089.7 in Q1 2025, and up 950.0% sequentially from $8000.0 in Q4 2025.
Biomerica (BMRA) Change in Inventory (2010 - 2026) Analysis & Trends
Biomerica (BMRA) has 17 years of Change in Inventory data on file, last reported at $84000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Inventory rose 146.41% year-over-year to $84000.0; the trailing twelve-month figure through Feb 2026 stood at -$34000.0 (up 93.73% YoY), and the FY2025 full-year result was -$882000.0, down 866.96% from the prior year.
- Change in Inventory advanced to $84000.0 in Q1 2026, from $8000.0 in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $338209.0 in Q1 2022 to a low of -$1.9 million in Q2 2022.
- A 5-year average of -$161104.2 and a median of -$71000.0 in 2023 frame the typical range for Change in Inventory.
- Across the five-year window, Change in Inventory sank 504.57% in 2022 and surged 659.46% in 2024, its largest moves.
- Tracing BMRA's Change in Inventory over 5 years: stood at -$69000.0 in 2022, then retreated by 2.9% to -$71000.0 in 2023, then sank by 119.72% to -$156000.0 in 2024, then soared by 105.13% to $8000.0 in 2025, then jumped by 950.0% to $84000.0 in 2026.
- Business Quant data shows BMRA's Change in Inventory at $84000.0 in Q1 2026, $8000.0 in Q4 2025, and -$10000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 420.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 127.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -399.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 65.20 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -264.59 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 171.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Biomerica | 4.85 Mn | 3.51 Mn | -44,000.00 | 84,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 84,000.00 |
| Feb 28, 2026 | 84,000.00 |
| Nov 30, 2025 | 8,000.00 |
| Nov 30, 2025 | 8,000.00 |
| Aug 31, 2025 | -10,000.00 |
| Aug 31, 2025 | -10,000.00 |
| May 31, 2025 | -116,000.00 |
| May 31, 2025 | -116,000.00 |
| Feb 28, 2025 | -181,000.00 |
| Feb 28, 2025 | -181,000.00 |
| Nov 30, 2024 | -156,000.00 |
| Nov 30, 2024 | -156,000.00 |
| Aug 31, 2024 | -429,000.00 |
| Aug 31, 2024 | -429,000.00 |
| May 31, 2024 | 224,000.00 |
| May 31, 2024 | 224,000.00 |
| Feb 29, 2024 | 281,000.00 |
| Feb 29, 2024 | 281,000.00 |
| Nov 30, 2023 | -71,000.00 |
| Nov 30, 2023 | -71,000.00 |